Advertisement
Case Report| Volume 30, ISSUE 2, P325-329, February 1999

Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation

      Abstract

      A 66-year-old white man had a hepatic resection for a 6-cm well-differentiated hepatocellular carcinoma which had developed in a non-cirrhotic liver. The only risk factors found were heavy drinking, smoking and heterozygosity for the C282Y mutation of the HFE gene. The liver was mildly fibrotic and overloaded with iron. It also contained numerous iron-free hepatocellular lesions from <1 to 10 mm, suggesting a premalignant change. These lesions were of three types: (i) iron-free foci, (ii) hyperplastic nodules and (iii) dysplastic nodules with severe dysplasia or even foci of well-differentiated grade I hepatocellular carcinoma. This observation suggests the possibility of malignant transformation of the liver in the newly-described syndrome of iron overload and normal transferrin saturation. It also illustrates the multistep process of carcinogenesis in the non-cirrhotic liver.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Deugnier YM
        • Charalambous P
        • Le Quilleuc D
        • Turlin B
        • Searle J
        • Brissot P
        • et al.
        Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients.
        Hepatology. 1993; 18: 1363-1369
        • Deugnier YM
        • Guyader D
        • Crantock L
        • Lopez J-M
        • Turlin B
        • Yaouanq J
        • et al.
        Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.
        Gastroenterology. 1993; 104: 228-234
        • Fellows IW
        • Stewart M
        • Jeffcoate WJ
        • Smith PG
        • Toghill PJ
        Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis.
        Gut. 1988; 29: 1603-1606
        • Blumberg RS
        • Chopra S
        • Ibrahim R
        • Crawford J
        • Farraye FA
        • Zeldis JB
        • et al.
        Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.
        Gastroenterology. 1988; 95: 1399-1402
        • Thompson NP
        • Stansby G
        • Jarmulowicz M
        • Hobbs KE
        • McIntyre N
        Hepatocellular carcinoma arising in non-cirrhotic haemochromatosis.
        HPB Surg. 1995; 8: 163-166
        • Goh J
        • Larney V
        • Ennis K
        • Clarke G
        • Callagy G
        • O'Keane JC
        • et al.
        Hepatocellular carcinoma may develop without cirrhosis in haemochromatosis.
        Hepatology. 1997; 26 ([abstract]): 514A
        • Bassett ML
        • Halliday JW
        • Powell LW
        Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.
        Hepatology. 1986; 6: 24-29
        • Watanabe S
        • Okita K
        • Harada T
        • Kodama T
        • Numa Y
        • Takemoto T
        • et al.
        Morphologic studies of the liver cell dysplasia.
        Cancer. 1983; 51: 2197-2205
        • Brissot P
        • Deugnier Y
        Genetic hemochromatosis.
        in: McIntyre N Benhamou J-P Bircher J Rizzetto M Rodes J Oxford Textbook of Clinical Hepatology. Oxford University Press, Oxford1991: 948-958
        • Brissot P
        Genetic hemochromatosis: recent advances.
        Hepatology Rapid Literature Review. 1996; 12: 11-17
        • Yoshida K
        • Furihata K
        • Takeda S
        • Nakamura A
        • Yamamoto K
        • Morita H
        • et al.
        A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans.
        Nature Genet. 1995; 9: 267-272
        • Gangaidzo IT
        • Gordeuk VR
        Hepatocellular carcinoma and African iron overload.
        Gut. 1995; 37: 727-730
        • Turlin B
        • Juguet F
        • Moirand R
        • Le Quilleuc D
        • Loréal O
        • Campion J-P
        • et al.
        Increased liver iron stores in patients with hepatocellular carcinoma developed on a non-cirrhotic liver.
        Hepatology. 1995; 22: 446-450
        • Moirand R
        • Mortaji AM
        • Loréal O
        • Paillard F
        • Brissot P
        • Deugnier Y
        A new syndrome of liver iron overload with normal transferrin saturation.
        Lancet. 1997; 349: 95-97
        • Deugnier Y
        • Moirand R
        • Jouanolle AM
        • Le Gall JY
        • Brissot P
        • David V
        HLA-H mutations in patients with iron overload and normal transferrin saturation.
        Hepatology. 1997; 26 ([abstract]): 199A
        • Deugnier Y
        • Turlin B
        • Loréal O
        Iron and neoplasia.
        J Hepatol. 1998; 28: 21-25
        • Yu MW
        • Gladek-Yarborough A
        • Chiamprasert S
        • Santella RM
        • Liaw YF
        • Chen C-J
        Cytochrome P450 2El and glutathione Stransferase M1 polymorphisms and susceptibility to hepatocellular carcinoma.
        Gastroenterology. 1995; 109: 1266-1273
        • Naccarato R
        • Farinati F
        Hepatocellular carcinoma, alcohol and cirrhosis: fact and hypotheses.
        Dig Dis Sci. 1991; 36: 1137-1142
        • Adams PC
        Iron overload in viral and alcoholic liver disease.
        J Hepatol. 1998; 28: 19-20
        • De Tomas J
        • Louredo A
        • Turégano F
        • Alonso A
        • Martin-Merino MR
        Hepatocellular carcinoma in a non-cirrhotic coal miner with secondary haemochromatosis.
        Eur J Gastroenterol Hepatol. 1997; 9: 633-634
        • Bralet M-P
        • Degott C
        • Belghiti J
        • Terris B
        Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinoma.
        J Hepatol. 1998; 28: 740-741
        • Terada T
        • Nakanuma Y
        Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic livers.
        Arch Pathol Lab Med. 1989; 113: 916-920
        • Terada T
        • Nakanuma Y
        Survey of iron-accumulative macroregenerative nodules in cirrhotic livers.
        Hepatology. 1989; 10: 851-854
        • Van Eyquen P
        • Sciot R
        • Callea F
        • Van Der Steen K
        • Moerman P
        • Desmet VJ
        The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study.
        Hepatology. 1988; 8: 1586-1595
        • Le Bail B
        • Faouzi S
        • Boussarie L
        • Balabaud C
        • Bioulac-Sage P
        • Rosenbaum J
        Extracellular matrix composition and integrin expression in early hepatocarcinogenesis in human cirrhotic liver.
        J Pathol. 1997; 181: 330-337
        • Hsia CC
        • Evarts RP
        • Nakasukasa H
        • Marsden ER
        • Thorgeirsson SS
        Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis.
        Hepatology. 1992; 16: 1327-1333
        • Williams G
        The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection.
        Toxicol Pathol. 1989; 17: 663-672